Milrinone

Specifications

78415-72-2CAS Number

278-903-6EC Number

6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrileIUPAC Name

C12H9N3OChemical Formula

211.22 g/molMolecular Weight

milrinone; 78415-72-2; Milrila; Milrinona; Milrinonum; Win-47203-2; 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile; DTXSID5023324; 6-methyl-2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridine-3-carbonitrile; JU9YAX04C7; WIN 47203; NSC-760072; WIN 47,203-2; (3,4'-BIPYRIDINE)-5-CARBONITRILE, 1,6-DIHYDRO-2-METHYL-6-OXO-; DTXCID103324; Corotrop; CHEBI:50693; (3,4'-Bipyridine)-5-carbonitrile, 6-dihydro-2-methyl-6-oxo-; [3,4'-Bipyridine]-5-carbonitrile, 1,6-dihydro-2-methyl-6-oxo-; Lactate, Milrinone; RefChem:57100; Win47203; C01CE02; 278-903-6; Primacor; Corotrope; 6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile; 2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile; MFCD00133539; 3-Cyano-6-methyl-5-(4-pyridyl)-2-pyridone; 1,6-Dihydro-2-methyl-6-oxo-(3,4'-bipyridine)-5-carbonitrile; CHEMBL189; 6-Methyl-5-(4-pyridyl)-2-pyridone-3-carbonitrile; 2-methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile; Milrinonum [Latin]; NCGC00015675-08; NCGC00164390-01; Milrinona [Spanish]; 1,6-Dihydro-2-methyl-6-oxo-[3,4'-bipyridine]-5-carbonitrile; CAS-78415-72-2; 2-Methyl-6-oxo-1,6-dihydro-[3,4']bipyridinyl-5-carbonitrile; YM 018; SMR000058475; Milrila (TN); WIN 47203-2; CCRIS 3795; SR-01000075524; EINECS 278-903-6; UNII-JU9YAX04C7; BRN 3546821; Milrinone?; Milrinone [USAN:USP:INN:BAN]; Milrinone (Standard); Tocris-1504; 111GE027; MILRINONE [INN]; MILRINONE [JAN]; MILRINONE [MI]; MILRINONE [USAN]; 1,2-DIHYDRO-6-METHYL-2-OXO-5-(4-PYRIDINYL)NICOTINONITRILE; Prestwick0_001065; Prestwick1_001065; Prestwick2_001065; Prestwick3_001065; Lopac-M-4659; MILRINONE [VANDF]; M1663; 2-Methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile (Milrinone); MILRINONE [MART.]; M 4659; MILRINONE [USP-RS]; MILRINONE [WHO-DD]; Milrinone (JAN/USP/INN); Lopac0_000737; SCHEMBL36947; BSPBio_001050; MLS000028818; MLS001424052; MLS006011946; BIDD:GT0197; Milrinone - Bio-X trade mark; SPBio_002965; BPBio1_001156; GTPL5225; orb1224003; orb1309788; SCHEMBL8309385; BDBM15296; 2-hydroxy-6-methyl-5-pyridin-4-ylpyridine-3-carbonitrile; 6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile; MILRINONE [USP MONOGRAPH]; GLXC-06520; HMS1571E12; HMS2051L10; HMS2090J14; HMS2098E12; HMS2234A23; HMS3262C16; HMS3267P12; HMS3370H18; HMS3393L10; HMS3656G06; HMS3715E12; HMS3742G09; HMS5081C11; Pharmakon1600-01505489; Tox21_112113; Tox21_400069; Tox21_500737; EBC-08195; HY-14252R; Milrinone, >=97% (TLC), powder; NSC760072; s2484; SBB055743; AKOS015836135; Tox21_112113_1; AC-4730; CCG-101020; CCG-204822; CS-1367; DB00235; FM26007; KS-1440; LP00737; NC00270; NSC 760072; SDCCGSBI-0050715.P002; NCGC00015675-01; NCGC00015675-02; NCGC00015675-03; NCGC00015675-04; NCGC00015675-05; NCGC00015675-06; NCGC00015675-07; NCGC00015675-09; NCGC00015675-11; NCGC00015675-24; NCGC00025189-01; NCGC00025189-02; NCGC00025189-03; NCGC00261422-01; BM164671; HY-14252; SMR004703527; SY028050; AB00514027; EU-0100737; M3344; NS00007740; SW197308-3; T1096; C07224; D00417; EN300-117244; AB00514027-02; AB00514027-03; AB00514027_04; AB00514027_05; AB00597139-08; F036508; Q847399; SR-01000075524-1; SR-01000075524-3; SR-01000075524-4; SR-01000075524-6; BRD-K67080878-001-05-5; BRD-K67080878-001-15-4; BRD-K67080878-001-16-2; Z1501480412; 6-methyl-2-oxo-5-(4-pyridyl)hydropyridine-3-carbonitrile; 1,2-dihydro-6-methyl-2-oxo-5-(4 -pyridinyl)nicotinonitrile; 2-Methyl-6-oxo-1,6-dihydro[3,4'-bipyridine]-5-carbonitrile; Milrinone, United States Pharmacopeia (USP) Reference Standard; 1,2-DIHYDRO-6-METHYL-2-OXO-5-(4-PYRIDINYL)-NICOTINONITRILE; 1,6-Dihydro-2-methyl-6-oxo-(3,4 inverted exclamation mark -bipyridine)-5-carbonitrileSynonyms